Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderRecruitingPhase 1 / Phase 22026-05-14NCT05413850

2 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Blue Earth Therapeutics Ltd3
PSI CRO8

21 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Beatson West of Scotland Cancer CenterGlasgowUnited Kingdom2
Biogenix Molecular LLCMiamiUnited States3
Bristol Hematology and Oncology CenterBristolUnited Kingdom1
Emory University HospitalAtlantaUnited States131
Hospital Rechts der IsarMunichGermany1
James Cook University HospitalMiddlesbroughUnited Kingdom6
Meander Medisch CentrumAmersfoortNetherlands17
NovaCure HealthMiamiUnited States1
Oxford University Hospitals NHS Foundation TrustOxfordUnited Kingdom24
Radboud UMCNijmegenNetherlands3
Saint Luc University HospitalBrusselsBelgium1
St Bartholomew's HospitalLondonUnited Kingdom40
University Hospital AachenAachenGermany4
University Hospital EssenEssenGermany17
University Hospital GhentGhentBelgium22
University Hospital LeuvenLeuvenBelgium14
University Hospital Southampton NHS Foundation TrustSouthamptonUnited Kingdom23
Universitätsklinikum AugsburgAugsburgGermany15
Weill Cornell Medicine - New York - Presbyterian HospitalNew YorkUnited States1
Weston ParkSheffieldUnited Kingdom1
XCancer Omaha / Urology Cancer CenterOmahaUnited States7